Always Over a Year Remaining Before Expiration (See bottom of bottle) Non-GMO, Gluten Free, Soy Free, Vegetarian Friendly, And 3rd Party Tested Made In a GMP Compliant, FDA Registered Facility
Cytokinol LS 9028 [INCI: Hydrolyzed Casein, Hydro the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least one anti-wrinkle and/or antiaging agent selected, for example and not restricted to, from the group consisting of the extracts or hydrolyzed extracts of Vitis vinifera, Rosa canina, Curcuma longa, Theobroma cacao, Ginkgo biloba, Leontopodium alpinum or Dunaliella salina among others, Matrixyl [INCI: Palmitoyl Pentapeptide-4], Matrixyl 3000 [INCI: Palmitoyl Tetrapeptide-7, Palmitoyl Oligopeptide], Matrixyl Synthe'6TM [INCI: Hydroxypropyl Cyclodextrin, Palmitoyl Tripeptide-38], EssenskinTM [INCI: Calcium Hydroxymethionine], Renovage [INCI: Teprenone], ResistemTM [INCI: Globularia cordifolia Ferment], Dermaxyl the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least one whitening or depigmenting agent or melanin synthesis inhibiting agent, selected, for example and not restricted to, from the extracts of Achillea millefolium, Aloe vera, Azadirachta indica, Asmina japonica, Artocarpus incisus, Bidens pilosa, Broussonetia papyrifera, Chlorella vulgaris, Cimicifuga racemosa, Emblica officinalis, Glycyrrhiza glabra, Glycyrthiza uralensis, Ilex purpurea, Ligusticum lucidum, Ligusticum walichii, Mitracarpus scaber, Morinda citrifoia, Morus alba, Morus bombycis, Naringi crenulata, Prunus domestica, Pseudostellaria radix, Rumex crispus, Rumex occidental the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least one natural extract or essential oil for the treatment of sensitive skin, selected from, for example and not restricted to, extracts of Abelmoschus esculentus , amaranth seed oil, oil from Alkanna tinctoria wood, Aloe vera, Althaea officinalis, Altingla excelsa, Andropogon virginicus, Aralla nucicaulis, Aralia racemosa, Argemone mexicana, Arnica montana, Artemsia vulgaris, Asarum maximum, Barleria prionitis, Calendula officinalis, Camella sinensis, Caesalpinia digyna, Campsis grandiflora, Capsicum spp., Carissa congesta, Carthamus oxyacantha, Cassia tora, Centipeda cunninghamii, Chamomilla recutita, Chrysanthemum in SymSitive 1609 [INCI: 4-t-Butylcyclohexanol], SymCareO [INCI: 4-t-Butylcydcohexanol, Bisabolol, Cetylhydroxyproline Palmitamide, Propamidobenzoic Acid, Brassica campestris (Rapeseed) Sterols, Zingiber officinale (Ginger) Root Extract] or SymCare W the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least one anti-itching agent selected from, for example and not restricted to, extracts of Abelmoschus esculentus, Actaea alba, Aglaia odorata, Alkanna tinctoria, Althaea officinalis, Altingla excelsa, Andropogon virginicus, Aralia nudicaulis, Aralla racemosa, Argemone mexicana, Barletia prionitis, Camelia sinensis, Caesalpinia digyna, Campsis grandiflora, Carissa congesta, Carthamus oxyacantha, Cassia tora, Chrysanthemum indicum, Cimicifuga racemosa, Cinnamomum camphora, Clematis vitalba, Cuscuta reflexa, Diospyros peregrina, Enicostema axillare, Hamamelis virginiana, Jatropha the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least one anti-inflammatory agent and/or analgesic is selected, for example and not restricted to, from the group consisting of extract of madecassoside, extract of echinacea , amaranth seed oil, sandal wood oil, extract of peach tree leaf, extract of Aloe vera, Arnica montana, Artemisia vulgaris, Asarum maximum, Calendula officinalls, Capsicum, Centipeda cunninghamii, Chamomilla recutita, Crinum asiaticum, Hamamelis virginlana, Harpagophytum procumbens, Hypericum perforatum, Lillum candidum, Malva sylvestris, Melaleuca alternifolia, Origanum majorana, Origanum vulgare, Prunus laurocerasus, Rosmarinus officinalls, Salix alba, Silybum marianum, Tanacetum the cosmetic or pharmaceutical composition of this invention can comprise a cosmetically or pharmaceutically effective quantity of at least anti-psoriasis, anti-dermatitis and/or anti-eczema agent, for example and not restricted to, corticosteroids, such as clobetasol, betamethasone, dexamethasone, halobetasol, diflorasone, fluocinonide, halcinonide, amcinonide, desoxymetasone, triamcinolone acetonide, mometasone, fluticasone, fluocinolone acetonide, flurandrenolide, desonide, prednicarbate, hydrocortisone, calcipotriene, vitamin D, anthralin, calcitriol, salicylic acid
Lancet 1984, 1: 689
1f which has now been corrected
47I L-Carnitine Therapy MIC B12 and Injectable Vitamins Weight Loss Therapies All Therapies and Services Sign in to view pricing & details Create a free account to see pricing, dosing, and the full details and to start your eligibility check so a licensed provider can confirm what's right for you
WO03047563 describes the use of propionyl L-carnitine, alone or in combination with sildenafil, for the treatment of erectile dysfunction
